Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 17

1.

Immune response to influenza A/H1N1 vaccine in inflammatory bowel disease patients treated with anti TNF-α agents: effects of combined therapy with immunosuppressants.

Andrisani G, Frasca D, Romero M, Armuzzi A, Felice C, Marzo M, Pugliese D, Papa A, Mocci G, De Vitis I, Rapaccini GL, Blomberg BB, Guidi L.

J Crohns Colitis. 2013 May;7(4):301-7. doi: 10.1016/j.crohns.2012.05.011. Epub 2012 Jun 5.

PMID:
22673636
[PubMed - indexed for MEDLINE]
Free PMC Article
2.

Risk of extraintestinal solid cancer with anti-TNF therapy in adults with inflammatory bowel disease: review of the literature.

Hudesman D, Lichtiger S, Sands B.

Inflamm Bowel Dis. 2013 Mar;19(3):644-9. doi: 10.1097/MIB.0b013e318280ebbd. Review.

PMID:
23314243
[PubMed - indexed for MEDLINE]
3.

Anti-TNF therapy in inflammatory bowel diseases: a huge review.

Peyrin-Biroulet L.

Minerva Gastroenterol Dietol. 2010 Jun;56(2):233-43. Review.

PMID:
20485259
[PubMed - indexed for MEDLINE]
4.

The safety of biologic agents in the treatment of inflammatory bowel disease.

Shepela C.

Minn Med. 2008 Jun;91(6):42-5. Review.

PMID:
18616021
[PubMed - indexed for MEDLINE]
5.

Optimizing anti-TNF treatment in inflammatory bowel disease.

Rutgeerts P, Van Assche G, Vermeire S.

Gastroenterology. 2004 May;126(6):1593-610. Review.

PMID:
15168370
[PubMed - indexed for MEDLINE]
6.

The London Position Statement of the World Congress of Gastroenterology on Biological Therapy for IBD with the European Crohn's and Colitis Organization: when to start, when to stop, which drug to choose, and how to predict response?

D'Haens GR, Panaccione R, Higgins PD, Vermeire S, Gassull M, Chowers Y, Hanauer SB, Herfarth H, Hommes DW, Kamm M, Löfberg R, Quary A, Sands B, Sood A, Watermeyer G, Lashner B, Lémann M, Plevy S, Reinisch W, Schreiber S, Siegel C, Targan S, Watanabe M, Feagan B, Sandborn WJ, Colombel JF, Travis S.

Am J Gastroenterol. 2011 Feb;106(2):199-212; quiz 213. doi: 10.1038/ajg.2010.392. Epub 2010 Nov 2. Review. Erratum in: Am J Gastroenterol. 2011 Feb;106(2):375. Watermayer, G [corrected to Watermeyer, G].

PMID:
21045814
[PubMed - indexed for MEDLINE]
7.

Certolizumab pegol for the management of Crohn's disease in adults.

Rivkin A.

Clin Ther. 2009 Jun;31(6):1158-76. doi: 10.1016/j.clinthera.2009.06.015. Review.

PMID:
19695385
[PubMed - indexed for MEDLINE]
8.

How to improve the safety of biologic therapy in Crohn's disease.

Ferkolj I.

J Physiol Pharmacol. 2009 Dec;60 Suppl 7:67-70. Review.

PMID:
20388947
[PubMed - indexed for MEDLINE]
Free Article
9.

Tumor necrosis factor-α monoclonal antibodies in the treatment of inflammatory bowel disease: clinical practice pharmacology.

Lee TW, Fedorak RN.

Gastroenterol Clin North Am. 2010 Sep;39(3):543-57. doi: 10.1016/j.gtc.2010.08.018. Review.

PMID:
20951917
[PubMed - indexed for MEDLINE]
10.

Role of the tumor necrosis factor antagonists in the treatment of inflammatory bowel disease: an update.

Leso V, Leggio L, Armuzzi A, Gasbarrini G, Gasbarrini A, Addolorato G.

Eur J Gastroenterol Hepatol. 2010 Jul;22(7):779-86. doi: 10.1097/MEG.0b013e328331b654. Review.

PMID:
19786877
[PubMed - indexed for MEDLINE]
11.

New strategies in the management of inflammatory bowel disease.

Rutgeerts P, Baert F.

Acta Clin Belg. 1999 Oct;54(5):274-80. Review.

PMID:
10555385
[PubMed - indexed for MEDLINE]
12.

[Crohn's disease--infliximab, adalimumab and certolizumab-pegol: clinical value of anti-TNF-alpha treatment].

Schreiber S.

Dtsch Med Wochenschr. 2007 Aug;132(34-35):1770-4. Review. German.

PMID:
17713889
[PubMed - indexed for MEDLINE]
13.

Tumor necrosis factor-alpha antibody for maintenance of remission in Crohn's disease.

Behm BW, Bickston SJ.

Cochrane Database Syst Rev. 2008 Jan 23;(1):CD006893. doi: 10.1002/14651858.CD006893. Review.

PMID:
18254120
[PubMed - indexed for MEDLINE]
14.

The influence of anti-TNF therapy on the course of chronic hepatitis C virus infection in patients with inflammatory bowel disease.

Lin MV, Blonski W, Buchner AM, Reddy KR, Lichtenstein GR.

Dig Dis Sci. 2013 Apr;58(4):1149-56. doi: 10.1007/s10620-012-2457-0. Epub 2012 Nov 20. Review.

PMID:
23179145
[PubMed - indexed for MEDLINE]
15.

[TNF-alpha blocking therapy in chronic inflammatory bowel disease].

Molnár T.

Orv Hetil. 2009 Sep 20;150(38):1773-9. doi: 10.1556/OH.2009.28689. Review. Hungarian.

PMID:
19740722
[PubMed - indexed for MEDLINE]
16.

Should my patient with inflammatory bowel disease on immunosuppressive therapy be vaccinated against influenza virus?

Narula N, Yamamura DL, Marshall JK.

Can J Gastroenterol. 2010 Feb;24(2):121-5. Review.

PMID:
20151071
[PubMed - indexed for MEDLINE]
Free PMC Article
17.

Potential prospects of nanomedicine for targeted therapeutics in inflammatory bowel diseases.

Pichai MV, Ferguson LR.

World J Gastroenterol. 2012 Jun 21;18(23):2895-901. doi: 10.3748/wjg.v18.i23.2895. Review.

PMID:
22736912
[PubMed - indexed for MEDLINE]
Free PMC Article

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk